Company / EPS (Basic)
Elanco EPS (Basic) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$0.47
FY2025
5-year range
-$2.50 / $0.68
FY2021-FY2025
Trend
-169.1%
vs FY2024
Sector context
#68 of 208
Health Care
What the data says
At $-0.47, Elanco's eps (basic) ranks #68 of 208 in the Health Care sector. EPS (Basic) has fluctuated over the past 8 years, ranging from $-2.50 in FY2023 to $0.68 in FY2024.
Based on SEC 10-K filings.
-0.47 in FY2025.
Improved from $-2.50 to $-0.47 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#68 of 208 in Health CareTop 33% of 208This company -$0.47 Sector average -$0.87
▼
+46.0% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 169.1% year-over-year.
- Ranks #68 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2024.
- Lowest eps (basic) in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.47 | -169.1% |
| FY2024 | $0.68 | +127.2% |
| FY2023 | -$2.50 | -1462.5% |
| FY2022 | -$0.16 | -188.9% |
| FY2021 | $0.18 | -35.7% |
| FY2020 | $0.28 | +126.4% |
| FY2019 | -$1.06 | - |
| FY2018 | - | - |
| FY2017 | -$1.06 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026